Mitochondrial biology may influence the outcome of therapy for acute promyelocytic leukemia if arsenic trioxide is not part of the treatment. Inclusion of arsenic trioxide in the treatment regimen may cancel the adverse impact of certain mitochondrial abnormalities frequently associated with the disease. Commentary on: Pereira-Martins et al. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. Br J Haematol 2023;200:170-174.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bjh.18534 | DOI Listing |
Publication Analysis
Top Keywords
acute promyelocytic
12
mitochondrial dna
8
dna content
8
arsenic trioxide
8
trioxide treatment
8
higher normal
4
mitochondrial
4
normal mitochondrial
4
content associated
4
associated better
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!